SOTERA HEALTH COMPANY Amortization of Intangible Assets
SOTERA HEALTH COMPANY (SHC) reported Amortization of Intangible Assets of $11.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- SOTERA HEALTH COMPANY amortization of intangible assets for the quarter ending 2026-06-30 was $5.56M, a 53.34% decline year-over-year.
- SOTERA HEALTH COMPANY amortization of intangible assets for the quarter ending 2026-03-31 was $5.60M, a 70.00% decline year-over-year.
- SOTERA HEALTH COMPANY amortization of intangible assets for the quarter ending 2025-12-31 was $5.55M, a 71.73% decline year-over-year.
- SOTERA HEALTH COMPANY amortization of intangible assets for the quarter ending 2025-09-30 was $5.65M, a 71.55% decline year-over-year.
- SOTERA HEALTH COMPANY amortization of intangible assets for fiscal 2025 was $41.80M, a 47.34% decline from fiscal 2024.
- SOTERA HEALTH COMPANY amortization of intangible assets for fiscal 2024 was $79.38M, a 2.42% decline from fiscal 2023.
- SOTERA HEALTH COMPANY amortization of intangible assets for fiscal 2023 was $81.35M, a 0.25% decline from fiscal 2022.
- SOTERA HEALTH COMPANY amortization of intangible assets for fiscal 2022 was $81.55M, a 5.98% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $11.16M 10-Q · filed 2026-08-06 | $16.72M derived: sum of 3 quarters · filed 2026-08-06 | $22.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $5.60M 10-Q · filed 2026-05-05 | $11.15M derived: sum of 2 quarters · filed 2026-05-05 | $16.80M derived: sum of 3 quarters · filed 2026-05-05 | $28.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $11.20M derived: sum of 2 quarters · filed 2026-02-24 | $23.12M derived: sum of 3 quarters · filed 2026-08-06 | $41.80M 10-K · filed 2026-02-24 |
| 2025-09-30 | $5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $17.57M derived: sum of 2 quarters · filed 2026-08-06 | $36.25M 10-Q · filed 2025-11-04 | $55.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $11.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.60M 10-Q · filed 2026-08-06 | $50.24M derived: sum of 3 quarters · filed 2026-08-06 | $70.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.67M 10-Q · filed 2026-05-05 | $38.31M derived: sum of 2 quarters · filed 2026-05-05 | $58.17M derived: sum of 3 quarters · filed 2026-05-05 | $77.93M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $19.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $39.50M derived: sum of 2 quarters · filed 2026-02-24 | $59.25M derived: sum of 3 quarters · filed 2026-02-24 | $79.38M 10-K · filed 2026-02-24 |
| 2024-09-30 | $19.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $39.61M derived: sum of 2 quarters · filed 2025-11-04 | $59.74M 10-Q · filed 2025-11-04 | $79.80M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $19.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $39.88M 10-Q · filed 2025-08-08 | $59.94M derived: sum of 3 quarters · filed 2026-02-24 | $80.12M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $20.12M 10-Q · filed 2025-05-01 | $40.18M derived: sum of 2 quarters · filed 2026-02-24 | $60.36M derived: sum of 3 quarters · filed 2026-02-24 | $80.86M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $20.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $40.24M derived: sum of 2 quarters · filed 2026-02-24 | $60.74M derived: sum of 3 quarters · filed 2026-02-24 | $81.35M 10-K · filed 2026-02-24 |
| 2023-09-30 | $20.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $40.68M derived: sum of 2 quarters · filed 2024-11-05 | $61.29M 10-Q · filed 2024-11-05 | $81.25M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $20.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $41.11M 10-Q · filed 2024-08-05 | $61.07M derived: sum of 3 quarters · filed 2025-02-27 | $81.28M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $20.61M 10-Q · filed 2024-05-02 | $40.56M derived: sum of 2 quarters · filed 2025-02-27 | $60.78M derived: sum of 3 quarters · filed 2025-02-27 | $81.98M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $19.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $40.18M derived: sum of 2 quarters · filed 2025-02-27 | $61.37M derived: sum of 3 quarters · filed 2025-02-27 | $81.55M 10-K · filed 2025-02-27 |
| 2022-09-30 | $20.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $41.41M derived: sum of 2 quarters · filed 2023-11-01 | $61.60M 10-Q · filed 2023-11-01 | $83.04M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $21.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $41.38M 10-Q · filed 2023-08-03 | $62.82M derived: sum of 3 quarters · filed 2024-02-27 | $84.06M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $20.18M 10-Q · filed 2023-05-03 | $41.63M derived: sum of 2 quarters · filed 2024-02-27 | $62.86M derived: sum of 3 quarters · filed 2024-02-27 | $84.64M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $21.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $42.68M derived: sum of 2 quarters · filed 2024-02-27 | $64.46M derived: sum of 3 quarters · filed 2024-02-27 | $86.74M 10-K · filed 2024-02-27 |
| 2021-09-30 | $21.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $43.02M derived: sum of 2 quarters · filed 2022-11-02 | $65.30M 10-Q · filed 2022-11-02 | $85.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $21.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $44.06M 10-Q · filed 2022-08-04 | $64.49M derived: sum of 3 quarters · filed 2023-02-28 | $84.69M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $22.28M 10-Q · filed 2022-05-05 | $42.71M derived: sum of 2 quarters · filed 2023-02-28 | $62.91M derived: sum of 3 quarters · filed 2023-02-28 | $82.62M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $20.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $40.63M derived: sum of 2 quarters · filed 2023-02-28 | $60.34M derived: sum of 3 quarters · filed 2023-02-28 | $80.25M 10-K · filed 2023-02-28 |
| 2020-09-30 | $20.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $39.91M derived: sum of 2 quarters · filed 2021-11-10 | $59.82M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $19.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $39.62M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $19.91M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $80.05M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |